Endemic Fungal Infections in Patients Receiving Tumour Necrosis Factor-α Inhibitor Therapy

Author： Smith Jeannina A.   Kauffman Carol A.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.69, Iss.11, 2009-07, pp. : 1403-1415

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Tumour Necrosis Factor-α Therapy for Rheumatoid and Other Inflammatory Arthropathies: Update on Safety in Older Patients

By Ornetti Paul   Chevillotte Hélène   Zerrak Amal   Jean Francis Maillefert  

Drugs & Aging, Vol. 23, Iss. 11, 2006-01 ,pp. : 855-860

Adis International

Access to resources Recommend Favorite

The Effects of Calcitriol Therapy on Serum Interleukin-1, Interleukin-6 and Tumour Necrosis Factor-α Concentrations in Post-menopausal Patients with Osteoporosis

By Inanir A   Özoran K   Tutkak H   Mermerci B  

The Journal of International Medical Research, Vol. 32, Iss. 6, 2004-11 ,pp. : 570-582

Field House Publishing

Access to resources Recommend Favorite

Tumour Necrosis Factor-α Levels in Non-diabetic Offspring of Patients with Type 2 Diabetes Mellitus

By Maltezos E   Papazoglou D   Exiara T   Papazoglou L   Karathanasis E   Christakidis D   Ktenidou-Kartali S  

The Journal of International Medical Research, Vol. 30, Iss. 6, 2002-11 ,pp. : 576-583

Field House Publishing

Access to resources Recommend Favorite

Leukaemic Transformation in Patients with Haematological Disease Receiving Tumour Necrosis Factor Inhibitors

By Ferrer-Marín Francisca   >   Vicente Vicente  

Clinical Drug Investigation, Vol. 32, Iss. 6, 2012-06 ,pp. : 423-426

Adis International

Access to resources Recommend Favorite

Tumour necrosis factor-α inhibitors/immunosuppressants: Cancer: 3 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1423, 2012-01 ,pp. : 48-48

Adis International

Access to resources Recommend Favorite